| 证券代码：300401 | 证券简称：花园生物 公告编号：2025-019 | | --- | --- | | 债券代码：123178 | 债券简称：花园转债 | 浙江花园生物医药股份有限公司 关于为全资子公司向银行申请授信额度提供担保的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏 浙江花园生物医药股份有限公司（以下简称"公司"）于2025年6月20日召开的第 七届董事会第十次会议、第七届监事会第七次会议分别审议通过了《关于为全资子公司 向银行申请授信额度提供担保的议案》。现将有关事项公告如下： 一、担保情况概述 为支持公司全资子公司浙江花园药业有限公司（以下简称"花园药业"）业务发展和 经营资金需求，公司同意拟为花园药业向银行申请授信提供总额度合计不超过人民币 30,000万元的连带责任信用担保（实际担保金额、种类、期限等以最终担保合同为准）， 占公司最近一期经审计净资产的9.32%。以上担保额度自董事会审议通过之日起一年内有 效，董事会授权公司董事长在上述额度范围内签署担保事项的相关法律文件。 根据《深圳证券交易所创业板股票上市规则》《公司章程》等相关 ...

| 证券代码：300401 | 证券简称：花园生物 | 公告编号：2025-021 | | --- | --- | --- | | 债券代码：123178 | 债券简称：花园转债 | | 浙江花园生物医药股份有限公司 第七届监事会第七次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 浙江花园生物医药股份有限公司（以下简称"公司"）第七届监事会第七次会议于 2025年6月20日以通讯表决方式召开。会议通知于2025年6月16日以邮件、电子通讯等方式 送达给全体监事。会议应参加表决监事3人，实际参加表决监事3人。会议符合《中华人民 共和国公司法》与《公司章程》的有关规定。 经审议，会议形成如下决议： 一、审议通过了《关于为全资子公司向银行申请授信额度提供担保的议案》 监事会认为公司为全资子公司向银行申请授信额度提供担保的财务风险在公司可控范 围内，有利于增强全资子公司的经营效率和盈利能力。该事项符合相关规定，不存在损害 公司及全体股东利益的情形，同意上述担保事项。 表决结果：3票同意，0票反对，0票弃权。 特此公告。 浙江花园生物医药股份有限公司监事 ...

证券代码：300401 证券简称：花园生物 债券代码：123178 债券简称：花园转债 民生证券股份有限公司（以下简称"民生证券"）编制本报告的内容及信息 来源于浙江花园生物医药股份有限公司（以下简称"花园生物"、"公司"或"发 行人"）对外公布的公开信息披露文件及发行人向民生证券提供的资料。民生证 券按照《公司债券发行与交易管理办法》《公司债券受托管理人执业行为准则》 浙江花园生物医药股份有限公司 向不特定对象发行可转换公司债券 受托管理事务报告 （2024 年度） 债券受托管理人 （中国（上海）自由贸易试验区浦明路 8 号） 二〇二五年六月 重要声明 《可转换公司债券管理办法》等相关规定及与花园生物签订的《受托管理协议》 的约定编制本报告。民生证券对本报告中所包含的从上述文件中引述内容和信息 未进行独立验证，也不就该等引述内容和信息的真实性、准确性和完整性做出任 何保证或承担任何责任。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜做出独立判断，而不应将本报告中的任何内容据以作为民生证券所作的承诺 或声明。请投资者独立征询专业机构意见，在任何情况下，投资者不能将本报告 作为投资行 ...

浙江花园生物医药股份有限公司 向不特定对象发行可转换公司债券 2025 年跟踪评级报告 | | | www.lhratings.com 1 声 明 一、本报告是联合资信基于评级方法和评级程序得出的截至发表之日的 独立意见陈述，未受任何机构或个人影响。评级结论及相关分析为联合资信 基于相关信息和资料对评级对象所发表的前瞻性观点，而非对评级对象的事 实陈述或鉴证意见。联合资信有充分理由保证所出具的评级报告遵循了真 实、客观、公正的原则。鉴于信用评级工作特性及受客观条件影响，本报告 在资料信息获取、评级方法与模型、未来事项预测评估等方面存在局限性。 二、本报告系联合资信接受浙江花园生物医药股份有限公司（以下简称 "该公司"）委托所出具，除因本次评级事项联合资信与该公司构成评级委 托关系外，联合资信、评级人员与该公司不存在任何影响评级行为独立、客 观、公正的关联关系。 联合〔2025〕3369 号 联合资信评估股份有限公司通过对浙江花园生物医药股份有限 公司主体及其相关债券的信用状况进行跟踪分析和评估，确定维持 浙江花园生物医药股份有限公司主体长期信用等级为 AA-，维持"花 园转债"信用等级为 AA-，评级展望为稳 ...

Report Summary - The report presents the top ten convertible bonds for May 2025 [1][10] Core Viewpoints - The report provides a detailed analysis of the top ten convertible bonds in May 2025, including their ratings, closing prices at the end of April, conversion premium rates, and P/E ratios of the underlying stocks. It also analyzes the business operations, financial performance, and company highlights of the corresponding issuing companies [10][20][30] Analysis of Each Convertible Bond 1. Zhongte Convertible Bond - Rating: AAA; 4 - month - end closing price: 107.723 yuan; Conversion premium rate: 111.03%; Underlying stock PE - TTM: 11.5 [10] - The company is a globally leading specialized special - steel material manufacturer with an annual production capacity of about 20 million tons. In 2024, its revenue was 109.203 billion yuan (-4.22% y/y), and in Q1 2025, revenue was 26.84 billion yuan (-5.59% y/y) [10] - Company highlights: It is one of the world's most comprehensive special - steel enterprises in terms of variety and specification, with over 20 million tons of annual production capacity. It has a complete industrial chain and is seeking external expansion opportunities [11] 2. Shanlu Convertible Bond - Rating: AAA; 4 - month - end closing price: 109.882 yuan; Conversion premium rate: 53.32%; Underlying stock PE - TTM: 3.7 [20] - The company's main business is road and bridge construction and maintenance. In 2024, its revenue was 71.348 billion yuan (-2.3% y/y), and in Q1 2025, revenue was 9.764 billion yuan (+1.95% y/y) [20] - Company highlights: It has the concept of "China - specific valuations" as its actual controller is the Shandong Provincial State - owned Assets Supervision and Administration Commission. It is expected to benefit from the infrastructure construction plan in Shandong during the 14th Five - Year Plan period [21] 3. Heshun Convertible Bond - Rating: AA -; 4 - month - end closing price: 126.801 yuan; Conversion premium rate: 23.13%; Underlying stock PE - TTM: 11.2 [30] - The company is a high - tech enterprise focusing on the R & D, production, and sales of polyamide 6 slices. In 2024, its revenue was 7.168 billion yuan (+19.11% y/y), and in Q1 2025, revenue was 1.563 billion yuan (-4.63% y/y) [30] - Company highlights: In 2024, the downstream market demand was good. It is promoting multiple new projects and actively expanding into the international market [31] 4. Aima Convertible Bond - Rating: AA; 4 - month - end closing price: 128.524 yuan; Conversion premium rate: 15.7%; Underlying stock PE - TTM: 17.6 [41] - The company is a leading enterprise in the electric two - wheeled vehicle industry. In 2024, its revenue was 21.606 billion yuan (+2.71% y/y), and in Q1 2025, revenue was 6.232 billion yuan (+25.82% y/y) [41] - Company highlights: The subsidy for trading in old vehicles may continue, and the implementation of the new national standard is expected to bring policy dividends and improve the gross profit margin [42] 5. Xingye Convertible Bond - Rating: AAA; 4 - month - end closing price: 116.521 yuan; Conversion premium rate: 24.23%; Underlying stock PE - TTM: 5.7 [51] - The company is one of the first joint - stock commercial banks established with the approval of the State Council and the People's Bank of China. In 2024, its revenue was 212.226 billion yuan (+0.66% y/y), and in Q1 2025, revenue was 55.683 billion yuan (-3.58% y/y) [51] - Company highlights: Its net interest income has grown steadily, asset quality is stable, and the scale has maintained stable growth [52] 6. Yonghe Convertible Bond - Rating: AA -; 4 - month - end closing price: 127.310 yuan; Conversion premium rate: 17.03%; Underlying stock PE - TTM: 32.7 [64] - The company's main business is the R & D, production, and sales of fluorochemical products. In 2024, its revenue was 4.606 billion yuan (+5.42% y/y), and in Q1 2025, revenue was 1.138 billion yuan (+12.36% y/y) [64] - Company highlights: In 2024, the prices of refrigerant products recovered, and the fluorochemical production base project of its subsidiary turned profitable [65] 7. Chongyin Convertible Bond - Rating: AAA; 4 - month - end closing price: 121.159 yuan; Conversion premium rate: 12.33%; Underlying stock PE - TTM: 7.2 [73] - The company is an early local joint - stock commercial bank in the upper reaches of the Yangtze River and Southwest China. In 2024, its revenue was 13.679 billion yuan (+3.54% y/y), and in Q1 2025, revenue was 3.581 billion yuan (+5.3% y/y) [73] - Company highlights: It is expected to benefit from the Chengdu - Chongqing Twin - City Economic Circle strategy. Its asset scale has grown steadily, and it actively follows national strategies [74] 8. Beigang Convertible Bond - Rating: AAA; 4 - month - end closing price: 127.2 yuan; Conversion premium rate: 12%; Underlying stock PE - TTM: 19.2 [85] - The company is located at an important transportation hub. In 2024, its revenue was 7.003 billion yuan (+0.77% y/y), and in Q1 2025, revenue was 1.643 billion yuan (+6.73% y/y) [85] - Company highlights: Its cargo and container throughput have increased, and it has a complete transportation network and is actively exploring the market [86] 9. Huayuan Convertible Bond - Rating: AA -; 4 - month - end closing price: 127.228 yuan; Conversion premium rate: 12.95%; Underlying stock PE - TTM: 26.2 [96] - The company focuses on building a complete vitamin D3 industry chain. In 2024, its revenue was 1.243 billion yuan (+13.58% y/y), and in Q1 2025, revenue was 0.326 billion yuan (-1.18% y/y) [96] - Company highlights: It is a leading enterprise in NF - grade cholesterol and 25 - hydroxyvitamin D3 products. It is expanding its product portfolio and has achievements in the pharmaceutical manufacturing field [98] 10. Yushui Convertible Bond - Rating: AAA; 4 - month - end closing price: 122.423 yuan; Conversion premium rate: 26.22%; Underlying stock PE - TTM: 27.7 [106] - The company is the largest integrated water supply and drainage enterprise in Chongqing. In 2024, its revenue was 6.999 billion yuan (-3.52% y/y), and in Q1 2025, revenue was 1.652 billion yuan (+8.66% y/y) [106] - Company highlights: It has a high market share in Chongqing's water supply and drainage market, is expanding externally, and has achieved good results in cost control [108]

Group 1: Market Overview - The three major stock indices experienced narrow fluctuations, with the North Stock 50 Index showing relative strength, while the Shanghai Composite Index fell by 0.05% to 3286.65 points, and the Shenzhen Component Index also dropped by 0.05% to 9849.8 points [1] - The total trading volume in the Shanghai, Shenzhen, and North Stock markets was 10,419 billion, a decrease of 350 billion from the previous day [1] - Sectors such as electricity and insurance declined, while home furnishings, automotive, chemicals, healthcare, agriculture, food and beverage, home appliances, and semiconductors saw gains [1] Group 2: Investment Opportunities in Smart Connected Vehicles - The Ministry of Industry and Information Technology (MIIT) has released key points for automotive standardization by 2025, emphasizing the need to strengthen standards for driving assistance and autonomous driving [2] - CITIC Securities anticipates that companies in the industry chain will focus on improving product maturity and safety, with main manufacturers expected to refine hardware and software architectures [2] - Investment recommendations include leading manufacturers in smart driving development, top suppliers of laser radar, and companies providing testing and simulation services for smart connected vehicles [2] Group 3: Smart Imaging Devices Market - The market for handheld smart imaging devices is projected to reach 36.47 billion in 2023, with a compound annual growth rate (CAGR) of approximately 12.9% from 2023 to 2027, potentially reaching 59.2 billion by 2027 [3] - The panoramic camera market is expected to reach 5 billion, with applications expanding beyond daily life and sports to include video conferencing and robotics [3] - The global market for action cameras is expected to exceed 30 billion in 2023, driven by the rise of outdoor sports [3] Group 4: Vitamin D3 Price Outlook - The price of feed-grade Vitamin D3 is at a historical low, leading to production cuts and supply reductions among some manufacturers [5] - Demand for Vitamin D3 is steadily increasing, with manufacturers reducing output since the beginning of 2024, resulting in historically low inventory levels [5] - Recent price increases have been observed, with significant adjustments in quotes from manufacturers, indicating potential for further price rises [5] Group 5: Consumption Policy and Tax Refunds - The National Taxation Administration has revised the management measures for tax refunds for outbound tourists, simplifying processes and expanding coverage to more small and medium-sized businesses [6] - CITIC Securities estimates that the potential market for tax refunds could reach nearly 100 billion, which may further stimulate consumption and expand domestic demand [6] - Key sectors to watch include traditional retail companies with strong operational capabilities and those involved in consumer infrastructure and travel services [6] Group 6: Electricity Market Developments - The National Development and Reform Commission and the National Energy Administration have announced plans to accelerate the construction of a national electricity spot market, aiming for full coverage by the end of 2025 [8] - Specific timelines have been set for the transition to formal operations in various provinces, with a focus on continuous settlement operations [8] Group 7: Digital Economy Infrastructure - The National Development and Reform Commission is promoting the construction of a national integrated computing network to optimize resource allocation and support the development of the digital economy [9] Group 8: Livestock Production Adjustments - The Ministry of Agriculture and Rural Affairs has issued a plan to adjust and optimize pig production capacity, focusing on monitoring and guiding the market [10]

沪指4月24日上涨0.03%，申万所属行业中，今日上涨的有10个，涨幅居前的行业为美容护理、银行， 涨幅分别为1.61%、1.16%。医药生物行业今日上涨0.25%。跌幅居前的行业为计算机、通信，跌幅分别 为2.36%、2.08%。 主力资金净流出的行业有25个，电子行业主力资金净流出规模居首，全天净流出资金66.21亿元，其次 是计算机行业，净流出资金为64.60亿元，净流出资金较多的还有机械设备、通信、汽车等行业。 医药生物行业今日上涨0.25%，全天主力资金净流入2.65亿元，该行业所属的个股共476只，今日上涨的 有243只，涨停的有10只；下跌的有218只，跌停的有3只。以资金流向数据进行统计，该行业资金净流 入的个股有204只，其中，净流入资金超5000万元的有10只，净流入资金居首的是双成药业，今日净流 入资金1.81亿元，紧随其后的是凯莱英、金凯生科，净流入资金分别为1.63亿元、1.37亿元。医药生物 行业资金净流出个股中，资金净流出超3000万元的有9只，净流出资金居前的有花园生物、迈瑞医疗、 智飞生物，净流出资金分别为8240.77万元、6250.66万元、6132.45万元。（数据宝） ...

| 证券代码：300401 | 证券简称：花园生物 | 公告编号：2025-017 | | --- | --- | --- | | 债券代码：123178 | 债券简称：花园转债 | | 浙江花园生物医药股份有限公司 2024 年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、浙江花园生物医药股份有限公司（以下简称"公司"或"本公司"）2024 年度 权益分配采用派息比例不变的权益分派方法； 2、公司回购账户不存在库存股份； 3、本次权益分派期间，"花园转债"不停止转股。 一、股东会审议通过权益分派方案 公司于 2025 年 4 月 15 日召开 2024 年年度股东会，审议通过了《关于 2024 年度利 润分配方案的议案 》，2024 年年度股 东会决议公告已于 当日在巨潮资讯网 （www.cninfo.com.cn）上披露。 1、公司 2024 年年度股东会审议通过的权益分配方案为：向全体股东每 10 股派发 现金股利人民币 1.14 元（含税）。公司最终以实施 2024 年度利润分配方案时股权登 记日的公司总股本为基数 ...

根据《公司向不特定对象发行可转换公司债券募集说明书》（以下简称"《募集说 明书》"）的规定，在本次发行之后，若公司发生派送股票股利、转增股本、增发新 股或配股、派送现金股利等情况（不包括因本次发行的可转债转股而增加股本的情形）， 则转股价格相应调整。具体的转股价格调整公式如下（保留小数点后两位，最后一位 四舍五入）： 派送股票股利或转增股本：P1=P0/（1+n）； | 证券代码：300401 | 证券简称：花园生物 | 公告编号：2025-018 | | --- | --- | --- | | 债券代码：123178 | 债券简称：花园转债 | | 浙江花园生物医药股份有限公司 关于可转换公司债券转股价格调整的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 重要内容提示： 一、关于"花园转债"转股价格调整的相关规定 经中国证券监督管理委员会"证监许可[2023]252 号"文同意注册的批复，浙江花 园生物医药股份有限公司（以下简称"公司"）于 2023 年 3 月 6 日向不特定对象发行 了 1,200 万张可转换公司债券，每张面值 100 元，发行总 ...

Core Points - The Shanghai Composite Index closed at 3296.36 points, below the six-month moving average, with a slight decline of -0.10% [1] - The total trading volume of A-shares reached 12,624.62 billion yuan [1] - A total of 176 A-shares have surpassed the six-month moving average, with notable stocks showing significant deviation rates [1] Summary of Stocks Exceeding Six-Month Moving Average - Stocks with the highest deviation rates include: - Jiyang Precision (13.55% deviation, latest price 22.22 yuan) [1] - Weimao Electronics (10.89% deviation, latest price 29.94 yuan) [1] - Sanmu Group (9.55% deviation, latest price 4.06 yuan) [1] - Other notable stocks with smaller deviation rates include: - David Medical (just above the six-month line) [1] - Ice Wheel Environment (just above the six-month line) [1] - Ningbo United (just above the six-month line) [1] Additional Stock Performance Data - The performance of several stocks on the day includes: - Dongbei Group (9.98% increase, latest price 5.62 yuan) [1] - Fenghua Co. (10.03% increase, latest price 13.05 yuan) [1] - Niuwei Co. (7.78% increase, latest price 26.33 yuan) [1] - The trading turnover rates for these stocks vary, with some exceeding 30% [1]